Search

Your search keyword '"Lønning, Per E."' showing total 368 results

Search Constraints

Start Over You searched for: Author "Lønning, Per E." Remove constraint Author: "Lønning, Per E."
368 results on '"Lønning, Per E."'

Search Results

2. Demystifying BRAF Mutation Status in Colorectal Liver Metastases: A Multi-institutional, Collaborative Approach to 6 Open Clinical Questions

5. A national precision cancer medicine implementation initiative for Norway

9. Supplementary Figure from Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers

10. Supplementary Table from Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers

11. Supplementary Data from A Mitochondrial Target Sequence Polymorphism in Manganese Superoxide Dismutase Predicts Inferior Survival in Breast Cancer Patients Treated with Cyclophosphamide

18. APOBEC3A /Bdeletion polymorphism and endometrial cancer risk

20. Demystifying BRAFMutation Status in Colorectal Liver Metastases

21. Epithelial to mesenchymal transition (EMT) is associated with attenuation of succinate dehydrogenase (SDH) in breast cancer through reduced expression of SDHC

23. Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers

24. White Blood Cell BRCA1 Promoter Methylation Status and Ovarian Cancer Risk

25. APOBEC3A/B deletion polymorphism and endometrial cancer risk.

26. Additional file 1 of Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy

27. Additional file 2 of Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy

28. Additional file 4 of Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy

29. Additional file 3 of Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy

31. The MDM2 Promoter SNP285C/309G Haplotype Diminishes Sp1 Transcription Factor Binding and Reduces Risk for Breast and Ovarian Cancer in Caucasians

36. Additional file 2 of Assessment of tumor suppressor promoter methylation in healthy individuals

37. Additional file 3 of Assessment of tumor suppressor promoter methylation in healthy individuals

39. Additional file 1 of Assessment of tumor suppressor promoter methylation in healthy individuals

41. Mutation of GATA3 in human breast tumors

42. C/EBPB-dependent Adaptation to Palmitic Acid Promotes Tumor Formation in Hormone Receptor Negative Breast Cancer

46. Molecular portraits of human breast tumours

Catalog

Books, media, physical & digital resources